A comparative study of 99mTc-YIGSR and 99mTc-MIBI uptake in tumor cells

J Huazhong Univ Sci Technolog Med Sci. 2005;25(6):712-4. doi: 10.1007/BF02896179.

Abstract

To investigate a new kind of tumor tracer 99mTc-YIGSR developed from a five amino structure (YIGSR) of the Laminin -chain, which can bind to the laminin receptors of tumor specifically, and radiolabeled with MAG3. (1) Preparation of the 99mTc-YIGSR probe: with S-Acetly-NH3-MAG3 as the chelator and with proper reductants YIGSR was labeled with 99mTc; (2) Cell culture and viability measurement: EAC was maintained in RPMI 1640 supplemented with calf serum; the trypan blue exclusion was applied to calculate the cell viability; (3) Study of the cell dynamic: The EAC's uptake of 99mTc-YIGSR and 99mTc-MIBI was observed at 37 degrees C and 22 degrees C, respectively. (1) The labeling efficiencies of 99mTc-YIGSR and 99mTc-MIBI were (62 +/- 3)% and (96 +/- 2)%, respectively; (2) The cell viability was declined with time of incubation; (3) At 37 degrees C, the EAC'S uptake of 99mTc-YIGSR and 99mTc-MIBI reached the peak of (43.16 +/- 2.4) % and (24.4 +/- 1.8) % at 60 min, respectively; and at 22 degrees C, the highest uptake was (26.5 +/- 2.1) % and (9.47 +/- 1.9) % at 60 min, respectively. The in vitro study suggests that 99mTc-YIGSR is superior to 99mTc-MIBI in cell uptake and has potential value in tumor imaging.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Carcinoma, Ehrlich Tumor / diagnostic imaging*
  • Female
  • Laminin
  • Oligopeptides
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics*
  • Rats
  • Technetium Tc 99m Mertiatide / pharmacokinetics*
  • Technetium Tc 99m Sestamibi / pharmacokinetics*
  • Tissue Distribution

Substances

  • Laminin
  • Oligopeptides
  • Radiopharmaceuticals
  • laminin 1
  • tyrosyl-isoleucyl-glycyl-seryl-arginine
  • Technetium Tc 99m Mertiatide
  • Technetium Tc 99m Sestamibi